Cuba vs Oman: Share of people with HIV who receive antiretroviral therapy
Cuba
68.0%
in 2024
Oman
68.0%
in 2024
Cuba rank
82nd
Oman rank
82nd
Share of people with HIV who receive antiretroviral therapy over time
- Cuba
- Oman
How they compare
Cuba currently reports 68.0% against 68.0% in Oman, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Oman ahead.
Cuba ranks 82nd and Oman ranks 82nd of 143 countries.
Across the 3 decades both report, Cuba averaged higher in 2 and Oman in 1.
Head to head by decade
| Decade | Cuba | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.1% | 18.5% | 4.4% | Oman |
| 2010s | 47.2% | 38.5% | 8.7% | Cuba |
| 2020s | 68.0% | 61.4% | 6.6% | Cuba |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of people with hiv who receive antiretroviral therapy, Cuba or Oman?
- Cuba, at 68.0% against 68.0% in Oman as of 2024.
- What is the difference in share of people with hiv who receive antiretroviral therapy between Cuba and Oman?
- 0.0%, with Cuba ahead.
- How many years of comparable data are there for Cuba and Oman?
- 25 years are reported by both, from 2000 to 2024.
- How do Cuba and Oman rank globally for share of people with hiv who receive antiretroviral therapy?
- Cuba ranks 82nd and Oman ranks 82nd of 143 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of people with HIV who receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.